罗米地辛联合环磷酰胺、阿霉素、长春新碱和泼尼松与单独使用环磷酰胺、阿霉素、长春新碱和泼尼松在未经治疗的外周T细胞淋巴瘤患者中的比较：Ro-CHOP试验的最终分析

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms2022 · 3,950 citations
2. 2Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)2021 · 196 citations
3. 3Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry2019 · 46 citations
4. 4Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas1999 · 3,495 citations
5. 5Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma2016 · 59 citations